Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection


DOI: https://dx.doi.org/10.18565/nephrology.2021.2.20-26

S.I. Rey, N.V. Vasina, G.A. Berdnikov, L.V. Marchenkova, O. N. Kotenko

1) N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department, Moscow, Russia; 2) Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department, Moscow, Russia; 3) City Clinical Hospital № 52 of the Moscow Department of Healthcare, Moscow, Russia
Objective. Provision of information on the organization of renal replacement therapy (RRT) in emergency medicine in hospitals of the Moscow Healthcare Department in the context of a pandemic of the novel coronavirus infection SARS-CoV2 (COVID-19).
Materials and methods. The annual reports of the Chief External Expert in Nephrology for 2019–2020 were used. Data were obtained from 43 healthcare organizations (HCO) that use RRT methods, of which 33 HCO used RRT methods for patients with COVID-19.
Results and conclusion. The COVID-19 pandemic led to a significant increase in the number of patients receiving RRT in the ICU, amounting to 9434 (of which with COVID-19 - 34.7%), which is 20.7% more than in 2019. Also, the number of patients with acute kidney injury (AKI) and “extrarenal indications” receiving RRT increased in 2020; an increase compared to 2019 amounted to 39.3 and 38.9%, respectively. There were 33.6 and 32.4% patients with COVID-19 in these groups, respectively. At the same time, the number of patients with CKD (55.2% - patients with COVID-19) who underwent RRT in the ICU decreased by 8.1% compared to 2019. The total number of RRT procedures in 2020 increased by 15% compared to 2019, with 34% of the total number for the year performed in patients with COVID-19 Compared to 2019, there was a statistically significant increase in mortality among ICU patients who received RRT in 2020, which amounted to 33.6% and 46.6%, respectively. The mortality rate of patients with COVID-19 was 62.5%, without COVID-19 - 38.1%.

About the Autors


Sergey I. Rey – Cand. Sci. (Med.), Senior Researcher, N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department; Leading Specialist at the Research Institute for Healthcare Organization and Medical Management of the Moscow Department of Healthcare, Moscow, Russia; e-mail: fanwal@mail.ru
Nadezhda V. Vasina – Cand. Sci. (Med.), Head of the Organizational and Methodological Department for Nephrology, Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department, Moscow, Russia; e-mail: vasina-olimp@mail.ru
Gennady A. Berdnikov – Cand. Sci. (Med.), Senior Researcher, N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department, Moscow, Russia; e-mail: BerdnikovGA@sklif.mos.ru
Lyudmila V. Marchenkova – Cand. Sci. (Med.), Specialist, Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department, Moscow, Russia; e-mail: marchen16@mail.ru
Oleg N. Kotenko – Cand. Sci. (Med.), Chief External Expert in Nephrology of the Moscow Healthcare Department, Head of the Moscow Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology, City Clinical Hospital № 52 of the Moscow Healthcare Department, Moscow, Russia; e-mail: olkotenko@yandex.ru


Similar Articles


Бионика Медиа